Cargando…

Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer

Detalles Bibliográficos
Autores principales: Yano, Akihiro, Kagawa, Makoto, Takeshita, Hideki, Okada, Yohei, Morozumi, Makoto, Kawakami, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859667/
https://www.ncbi.nlm.nih.gov/pubmed/30924454
http://dx.doi.org/10.4103/aja.aja_9_19
_version_ 1783471162802569216
author Yano, Akihiro
Kagawa, Makoto
Takeshita, Hideki
Okada, Yohei
Morozumi, Makoto
Kawakami, Satoru
author_facet Yano, Akihiro
Kagawa, Makoto
Takeshita, Hideki
Okada, Yohei
Morozumi, Makoto
Kawakami, Satoru
author_sort Yano, Akihiro
collection PubMed
description
format Online
Article
Text
id pubmed-6859667
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68596672019-12-05 Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer Yano, Akihiro Kagawa, Makoto Takeshita, Hideki Okada, Yohei Morozumi, Makoto Kawakami, Satoru Asian J Androl Letter to the Editor Wolters Kluwer - Medknow 2019-03-26 /pmc/articles/PMC6859667/ /pubmed/30924454 http://dx.doi.org/10.4103/aja.aja_9_19 Text en Copyright: © The Author(s)(2019) http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letter to the Editor
Yano, Akihiro
Kagawa, Makoto
Takeshita, Hideki
Okada, Yohei
Morozumi, Makoto
Kawakami, Satoru
Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title_full Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title_fullStr Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title_full_unstemmed Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title_short Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
title_sort initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859667/
https://www.ncbi.nlm.nih.gov/pubmed/30924454
http://dx.doi.org/10.4103/aja.aja_9_19
work_keys_str_mv AT yanoakihiro initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer
AT kagawamakoto initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer
AT takeshitahideki initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer
AT okadayohei initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer
AT morozumimakoto initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer
AT kawakamisatoru initial3monthdynamicsofdehydroepiandrosteronesulfatecanpredictresponsivenesstoprimaryandrogendeprivationtherapyinpatientswithmetastaticprostatecancer